Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Harrington

Showing results (781-790 of 789) with videos related to

Pageof 79
Sort By:
You have reached the last page of results.This site can display upto 789 results.
The Lancet. HIV|March 27, 2024
Safety and pharmacokinetics of oral and long-acting injectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding studyAditya H Gaur, Edmund V Capparelli, Katherine Calabrese, et al.
Physical Review Letters|January 13, 2019
Piezoelectrically Tuned Multimode Cavity Search for Axion Dark MatterC Boutan, M Jones, B H LaRoque, et al.
Nature Genetics|November 21, 2023
Multi-ancestry genome-wide association study of cannabis use disorder yields insight into disease biology and public health implicationsDaniel F Levey, Marco Galimberti, Joseph D Deak, et al.
The Lancet Regional Health. Europe|November 21, 2022
Policy implementation and priorities to create healthy food environments using the Healthy Food Environment Policy Index (Food-EPI): A pooled level analysis across eleven European countriesElisa Pineda, Maartje P Poelman, Anu Aaspõllu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 2, 2020
Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR TrialsGiuliano Rizzardini, Edgar T Overton, Chloe Orkin, et al.
Physical Review Letters|March 29, 2020
Extended Search for the Invisible Axion with the Axion Dark Matter ExperimentT Braine, R Cervantes, N Crisosto, et al.
Journal of Medicinal Chemistry|August 1, 2015
Discovery of VX-509 (Decernotinib): A Potent and Selective Janus Kinase 3 Inhibitor for the Treatment of Autoimmune DiseasesLuc J Farmer, Mark W Ledeboer, Thomas Hoock, et al.
The Review of Scientific Instruments|January 1, 2022
Axion Dark Matter Experiment: Detailed design and operationsR Khatiwada, D Bowring, A S Chou, et al.
Obesity Facts|October 24, 2022
Obesity in Adults: A 2022 Adapted Clinical Practice Guideline for IrelandCathy Breen, Jean O'Connell, Justin Geoghegan, et al.
Pageof 79

Showing results (781-790 of 789) with videos related to

Sort By:
Pageof 79
You have reached the last page of results.This site can display upto 789 results.
The Lancet. HIV|March 27, 2024
Safety and pharmacokinetics of oral and long-acting injectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding studyAditya H Gaur, Edmund V Capparelli, Katherine Calabrese, et al.
Physical Review Letters|January 13, 2019
Piezoelectrically Tuned Multimode Cavity Search for Axion Dark MatterC Boutan, M Jones, B H LaRoque, et al.
Nature Genetics|November 21, 2023
Multi-ancestry genome-wide association study of cannabis use disorder yields insight into disease biology and public health implicationsDaniel F Levey, Marco Galimberti, Joseph D Deak, et al.
The Lancet Regional Health. Europe|November 21, 2022
Policy implementation and priorities to create healthy food environments using the Healthy Food Environment Policy Index (Food-EPI): A pooled level analysis across eleven European countriesElisa Pineda, Maartje P Poelman, Anu Aaspõllu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 2, 2020
Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR TrialsGiuliano Rizzardini, Edgar T Overton, Chloe Orkin, et al.
Physical Review Letters|March 29, 2020
Extended Search for the Invisible Axion with the Axion Dark Matter ExperimentT Braine, R Cervantes, N Crisosto, et al.
Journal of Medicinal Chemistry|August 1, 2015
Discovery of VX-509 (Decernotinib): A Potent and Selective Janus Kinase 3 Inhibitor for the Treatment of Autoimmune DiseasesLuc J Farmer, Mark W Ledeboer, Thomas Hoock, et al.
The Review of Scientific Instruments|January 1, 2022
Axion Dark Matter Experiment: Detailed design and operationsR Khatiwada, D Bowring, A S Chou, et al.
Obesity Facts|October 24, 2022
Obesity in Adults: A 2022 Adapted Clinical Practice Guideline for IrelandCathy Breen, Jean O'Connell, Justin Geoghegan, et al.
Pageof 79